{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:06:26Z","timestamp":1793113586767,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-05856-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:24:56Z","timestamp":1773663896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular markers of antimalarial drug resistance in pfk13, pfmdr1, pfdhfr, and pfdhps genes of Plasmodium falciparum in a rural municipality in Cubal, Benguela Province, Angola (2022\u20132023)"],"prefix":"10.1186","volume":"25","author":[{"given":"Alejandro","family":"Mediavilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xana","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00ednez-Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Molina-de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Febrer-Sendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroa","family":"Silgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheta","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles Rubio","family":"Maturana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlette","family":"Nindia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ednez-Campreci\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Oliveira-Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sulleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berzosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"5856_CR1","doi-asserted-by":"publisher","DOI":"10.30875\/9789287074560","volume-title":"World malaria report 2025","author":"World Health Organization (WHO)","year":"2025","unstructured":"World Health Organization (WHO). World malaria report 2025. Geneva: WHO; 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240117822. Accessed 27 Jan 2026."},{"key":"5856_CR2","unstructured":"Minist\u00e9rio da Sa\u00fade de Angola. Manual de diagn\u00f3stico e tratamento da mal\u00e1ria. Luanda; 2022. https:\/\/es.scribd.com\/document\/678479391\/Manual-de-Diagno-stico-e-Tto-da-Mala-ria-2022-013722-formatado. Accessed 27 Jan 2026."},{"key":"#cr-split#-5856_CR3.1","unstructured":"U.S. President's Malaria Initiative. Angola Malaria Operational Plan FY 2024. PMI"},{"key":"#cr-split#-5856_CR3.2","unstructured":"2024. https:\/\/mesamalaria.org\/wp-content\/uploads\/2025\/04\/ANGOLA-Malaria-Profile-PMI-FY-2024-1.pdf. Accessed 27 Jan 2026."},{"key":"5856_CR4","unstructured":"Minist\u00e9rio da Sa\u00fade de Angola. Plano Nacional de Desenvolvimento Sanit\u00e1rio 2012\u20132025, Volume II. Luanda; 2012. https:\/\/admin.mat.gov.ao\/uploads\/relatorio_final_comissao_multissectorial_pnds_200663155760b0a64397ffa_22f23d9be1.pdf. Accessed 27 Jan 2026."},{"key":"5856_CR5","doi-asserted-by":"publisher","DOI":"10.2471\/B09145","volume-title":"WHO guidelines for malaria","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. WHO guidelines for malaria. Geneva: WHO; 2024.\u00a0https:\/\/media.malariaworld.org\/B09146_eng_e61c150520.pdf. Accessed 27 Jan 2026."},{"key":"5856_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","volume":"22","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, Asua V, Conrad MD. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nat Rev Microbiol. 2024;22:373\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"5856_CR7","unstructured":"World Health Organization. Directrices de la OMS sobre la malaria. Geneva: OMS; 2025. https:\/\/www.who.int\/es\/teams\/global-malaria-programme\/guidelines-for-malaria. Accessed 27 Jan 2026."},{"key":"5856_CR8","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"ACCESS-SMC Partnership","year":"2020","unstructured":"ACCESS-SMC Partnership. Effectiveness of seasonal malaria chemoprevention at scale in West and Central Africa: An observational study. Lancet. 2020;396:1829\u201340.","journal-title":"Lancet"},{"key":"5856_CR9","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04740-x","volume":"22","author":"I Molina-de la Fuente","year":"2023","unstructured":"Molina-de la Fuente I, Sagrado Benito MJ, Lasry E, Ousley J, Garc\u00eda L, Gonz\u00e1lez V, et al. Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: Malaria morbidity and molecular drug resistance profiles in South Sudan. Malar J. 2023;22:147.","journal-title":"Malar J"},{"key":"5856_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105704","volume":"212","author":"L Sitali","year":"2020","unstructured":"Sitali L, Mwenda MC, Miller JM, Bridges DJ, Hawela MB, Hamainza B, et al. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch13, Pfmdr1 and Pfdhfr\/Pfdhps genes. Acta Trop. 2020;212:105704.","journal-title":"Acta Trop"},{"key":"5856_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","volume":"93","author":"L Cui","year":"2015","unstructured":"Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. Am J Trop Med Hyg. 2015;93:57\u201368.","journal-title":"Am J Trop Med Hyg"},{"key":"5856_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, Macinnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"},{"key":"5856_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5856_CR14","doi-asserted-by":"publisher","DOI":"10.30875\/f309483f-en","volume-title":"World malaria report 2018","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. World malaria report 2018. Geneva: WHO; 2018.\u00a0https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2018. Accessed 27 Jan 2026."},{"key":"5856_CR15","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva: WHO; 2019.\u00a0https:\/\/www.who.int\/publications\/i\/item\/9789240012813. Accessed 27 Jan 2026."},{"key":"5856_CR16","volume-title":"Malaria: artemisinin partial resistance","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Malaria: artemisinin partial resistance. Geneva: WHO; 2025.\u00a0https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/artemisinin-resistance. Accessed 27 Jan 2026."},{"key":"5856_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijid.2023.11.026","volume":"139","author":"G Mesia Kahunu","year":"2024","unstructured":"Mesia Kahunu G, Wellmann Thomsen S, Wellmann Thomsen L, Muhindo Mavoko H, Mitashi Mulopo P, Filtenborg Hocke E, et al. Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo. Int J Infect Dis. 2024;139:41\u20139.","journal-title":"Int J Infect Dis"},{"key":"5856_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4269\/ajtmh.23-0740","volume":"110","author":"W van Loon","year":"2024","unstructured":"van Loon W, Bisimwa BC, Byela V, Kirby R, Bugeme PM, Balagizi A, et al. Detection of artemisinin resistance marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022. Am J Trop Med Hyg. 2024;110:653\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"5856_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03613-5","volume":"20","author":"F Huang","year":"2021","unstructured":"Huang F, Yan H, Xue JB, Cui YW, Zhou SS, Xia ZG, et al. Molecular surveillance of pfcrt, pfmdr1 and pfk13-propeller mutations in Plasmodium falciparum isolates imported from Africa to China. Malar J. 2021;20:1\u201312.","journal-title":"Malar J"},{"key":"5856_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/infdis\/jiaf188","volume":"232","author":"AC Martin","year":"2025","unstructured":"Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, et al. Emergence and rising prevalence of artemisinin partial resistance marker Kelch13 P441L in a low malaria transmission setting in Southern Zambia. J Infect Dis. 2025;232:918\u201322.","journal-title":"J Infect Dis"},{"key":"5856_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-024-08301-2","volume":"123","author":"CS Milong Melong","year":"2024","unstructured":"Milong Melong CS, Peloewetse E, Russo G, Tamgue O, Tchoumbougnang F, Paganotti GM. An overview of artemisinin-resistant malaria and associated Pfk13 gene mutations in Central Africa. Parasitol Res. 2024;123:1\u201312.","journal-title":"Parasitol Res"},{"key":"5856_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-022-04095-9","volume":"21","author":"S Das","year":"2022","unstructured":"Das S, K\u00e9rah-Hinzoumb\u00e9 C, Kebf\u00e9n\u00e9 M, Srisutham S, Nagorngar TY, Saralamba N, et al. Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016\u20132017. Malar J. 2022;21:1\u201312.","journal-title":"Malar J"},{"key":"5856_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01949-20","volume":"65","author":"PR Dimbu","year":"2021","unstructured":"Dimbu PR, Horth R, C\u00e2ndido ALM, Ferreira CM, Caquece F, Garcia LEA, et al. Continued low efficacy of artemether-lumefantrine in Angola in 2019. Antimicrob Agents Chemother. 2021;65:e01949-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05228-8","volume":"20","author":"D She","year":"2020","unstructured":"She D, Wang Z, Liang Q, Lu L, Huang Y, Zhang K, et al. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China. BMC Infect Dis. 2020;20:228.","journal-title":"BMC Infect Dis"},{"key":"5856_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00552-19","volume":"63","author":"R Zhou","year":"2019","unstructured":"Zhou R, Yang C, Li S, Zhao Y, Liu Y, Qian D, et al. Molecular surveillance of drug resistance of Plasmodium falciparum isolates imported from Angola in Henan Province, China. Antimicrob Agents Chemother. 2019;63:e00552-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16:1\u201310.","journal-title":"Malar J"},{"key":"5856_CR27","doi-asserted-by":"publisher","first-page":"e1119","DOI":"10.1093\/infdis\/jiaf155","volume":"231","author":"C Fan\u00e7ony","year":"2025","unstructured":"Fan\u00e7ony C, Fortes-Gabriel E, Zage F, Alexiou E, Broumou I, Pernaute-Lau L, et al. Artemether-lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections. J Infect Dis. 2025;231:e1119\u201328.","journal-title":"J Infect Dis"},{"key":"5856_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01525-23","volume":"68","author":"PR Dimbu","year":"2024","unstructured":"Dimbu PR, Labuda S, Ferreira CM, Caquece F, Andr\u00e9 K, Pembele G, et al. Therapeutic response to four artemisinin-based combination therapies in Angola, 2021. Antimicrob Agents Chemother. 2024;68:e0152523.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Florinda Jo\u00e3o M, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17:229.","journal-title":"Malar J"},{"key":"5856_CR30","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s11686-024-00923-x","volume":"69","author":"KS Millogo","year":"2024","unstructured":"Millogo KS, Kabor\u00e9 B, Sondo P, Compaor\u00e9 EW, Kouevi AFC, Kambou SAE, et al. Trend of N86Y and Y184F mutations in Pfmdr1 gene in children under seasonal malaria chemoprevention coverage in Nanoro, Burkina Faso. Acta Parasitol. 2024;69:1967\u201376.","journal-title":"Acta Parasitol"},{"key":"5856_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/950424","volume":"2014","author":"ZO Ibraheem","year":"2014","unstructured":"Ibraheem ZO, Abd Majid R, Noor SM, Sedik HM, Basir R. Role of different pfcrt and pfmdr1 mutations in conferring resistance to antimalaria drugs in Plasmodium falciparum. Malar Res Treat. 2014;2014:1\u20139.","journal-title":"Malar Res Treat"},{"key":"5856_CR32","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gn\u00e4dig N, Uhlemann AC, et al. Globally prevalent Pfmdr1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun"},{"key":"5856_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(22)00593-X","volume":"23","author":"KB Beshir","year":"2023","unstructured":"Beshir KB, Muwanguzi J, Nader J, Mansukhani R, Traore A, Gamougam K, et al. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine\u2013pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. Lancet Infect Dis. 2023;23:361\u201370.","journal-title":"Lancet Infect Dis"},{"key":"5856_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-1018-3","volume":"14","author":"K Kiaco","year":"2015","unstructured":"Kiaco K, Teixeira J, Machado M, Do Ros\u00e1rio V, Lopes D. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Malar J. 2015;14:1018.","journal-title":"Malar J"},{"key":"5856_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00712-4","volume":"9","author":"H Quan","year":"2020","unstructured":"Quan H, Igbasi U, Oyibo W, Omilabu S, Chen SB, Shen HM, et al. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria. Infect Dis Poverty. 2020;9:72.","journal-title":"Infect Dis Poverty"},{"key":"5856_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-04000-w","volume":"20","author":"P Berzosa","year":"2021","unstructured":"Berzosa P, de la Fuente MI, Ta-Tang TH, Gonz\u00e1lez V, Garc\u00eda L, Rodr\u00edguez-Galet A, et al. Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20 years (1999 to 2019). Malar J. 2021;20:1\u201312.","journal-title":"Malar J"},{"key":"5856_CR37","first-page":"1","volume":"8","author":"H Quan","year":"2023","unstructured":"Quan H, Yu P, Kassegne K, Shen HM, Chen SB, Chen JH. Polymorphism of drug resistance genes dhfr and dhps in Plasmodium falciparum isolates among Chinese migrant workers who returned from Ghana in 2013. Trop Med Infect Dis. 2023;8:1\u201311.","journal-title":"Trop Med Infect Dis"},{"key":"5856_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00211-2","volume":"4","author":"E Gu\u00e9mas","year":"2023","unstructured":"Gu\u00e9mas E, Copp\u00e9e R, M\u00e9nard S, du Manoir M, Nsango S, Makaba Mvumbi D, et al. Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine\u2013pyrimethamine in Central Africa: a cross-sectional study. Lancet Microbe. 2023;4:e983\u201393.","journal-title":"Lancet Microbe"},{"key":"5856_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo I, Roper C. Mapping \u201cpartially resistant\u201d, \u201cfully resistant\u201d, and \u201csuper resistant\u201d malaria. Trends Parasitol. 2013;29:505\u201315.","journal-title":"Trends Parasitol"},{"key":"5856_CR40","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1128\/AAC.00024-09","volume":"53","author":"CJ Sutherland","year":"2009","unstructured":"Sutherland CJ, Fifer H, Pearce RJ, Bin Reza F, Nicholas M, Haustein T, et al. Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom. Antimicrob Agents Chemother. 2009;53:3405\u201310.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","volume":"6","author":"MC Oguike","year":"2016","unstructured":"Oguike MC, Falade CO, Shu E, Enato IG, Watila I, Baba ES, et al. Molecular determinants of sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V. Int J Parasitol Drugs Drug Resist. 2016;6:220\u20139.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5856_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-023-04487-5","volume":"22","author":"AJ Adegbola","year":"2023","unstructured":"Adegbola AJ, Ijarotimi OA, Ubom AE, Adesoji BA, Babalola OE, Hocke EF, et al. A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine\u2013pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria. Malar J. 2023;22:1\u201310.","journal-title":"Malar J"},{"key":"5856_CR43","volume-title":"WHO policy recommendation on intermittent preventive treatment during infancy with sulphadoxine\u2013pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. WHO policy recommendation on intermittent preventive treatment during infancy with sulphadoxine\u2013pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: WHO; 2010.\u00a0https:\/\/www.who.int\/publications\/i\/item\/WHO-IVB-11.07. Accessed 27 Jan 2026."},{"key":"5856_CR44","volume-title":"WHO Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. WHO Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy. Geneva: WHO; 2013.\u00a0https:\/\/www.who.int\/docs\/default-source\/malaria\/mpac-documentation\/mpac-sep13-erg-ipt-malaria-pregnancy-report.pdf. Accessed 27 Jan 2026."},{"key":"5856_CR45","volume-title":"Updated WHO recommendations for malaria chemoprevention among children and pregnant women","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Updated WHO recommendations for malaria chemoprevention among children and pregnant women. Geneva: WHO; 2022.\u00a0https:\/\/www.who.int\/news\/item\/03-06-2022-Updated-WHO-recommendations-for-malaria-chemoprevention-among-children-and-pregnant-women. Accessed 27 Jan 2026."},{"key":"5856_CR46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","volume":"19","author":"AM van Eijk","year":"2019","unstructured":"van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, et al. Effect of Plasmodium falciparum sulfadoxine\u2013pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:546\u201356.","journal-title":"Lancet Infect Dis"},{"key":"5856_CR47","doi-asserted-by":"publisher","first-page":"e01601","DOI":"10.1128\/aac.01601-22","volume":"67","author":"SR Rosillo","year":"2023","unstructured":"Rosillo SR, Dimbu PR, C\u00e2ndido ALM, Oh JHM, Ferreira CM, Andrade BN, et al. Molecular markers of sulfadoxine\u2013pyrimethamine resistance in samples from children with uncomplicated Plasmodium falciparum at three sites in Angola in 2019. Antimicrob Agents Chemother. 2023;67:e01601-e1622.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR48","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s41467-020-15779-8","volume":"11","author":"R Verity","year":"2020","unstructured":"Verity R, Aydemir O, Brazeau NF, Watson OJ, Hathaway NJ, Mwandagalirwa MK, et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat Commun. 2020;11:2107.","journal-title":"Nat Commun"},{"key":"5856_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13071-025-06685-3","volume":"18","author":"A Mediavilla","year":"2025","unstructured":"Mediavilla A, Febrer-Sendra B, Silgado A, Crego-Vicente B, Mart\u00ednez-Vallejo P, Nindia A, et al. Evaluation of dried blood spot sampling for real-time PCR malaria diagnostics in a rural setting in Angola. Parasit Vectors. 2025;18:44.","journal-title":"Parasit Vectors"},{"key":"5856_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13071-024-06467-3","volume":"17","author":"A Mediavilla","year":"2024","unstructured":"Mediavilla A, Silgado A, Febrer-Sendra B, Crego-Vicente B, Mart\u00ednez-Vallejo P, Maturana CR, et al. Real-time PCR for malaria diagnosis and identification of Plasmodium species in febrile patients in Cubal. Angola Parasit Vectors. 2024;17:384.","journal-title":"Angola Parasit Vectors"},{"key":"5856_CR51","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1128\/AAC.00559-12","volume":"56","author":"C Fan\u00e7ony","year":"2012","unstructured":"Fan\u00e7ony C, Gamboa D, Sebasti\u00e3o Y, Hallett R, Sutherland C, Sousa-Figueiredo JC, et al. Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in Northern Angola. Antimicrob Agents Chemother. 2012;56:5271\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1475-2875-8-275","volume":"8","author":"AK Rowe","year":"2009","unstructured":"Rowe AK, De Le\u00e1n GFP, Mihigo J, Santelli ACF, Miller NP, Van-Dnem P. Quality of malaria case management at outpatient health facilities in Angola. Malar J. 2009;8:275.","journal-title":"Malar J"},{"key":"5856_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-022-04424-y","volume":"21","author":"W Tavares","year":"2022","unstructured":"Tavares W, Morais J, Martins JF, Scalsky RJ, Stabler TC, Medeiros MM, et al. Malaria in Angola: recent progress, challenges and future opportunities using parasite demography studies. Malar J. 2022;21:1\u201312.","journal-title":"Malar J"},{"key":"5856_CR54","first-page":"1","volume":"14","author":"F Salvador","year":"2015","unstructured":"Salvador F, Cossio Y, Riera M, S\u00e1nchez-Montalv\u00e1 A, Bocanegra C, Mendioroz J, et al. Changes in malaria epidemiology in a rural area of Cubal. Angola Malar J. 2015;14:1\u20136.","journal-title":"Angola Malar J"},{"key":"5856_CR55","unstructured":"Instituto Nacional de Estat\u00edstica (INE) Angola. Inqu\u00e9rito de Indicadores M\u00faltiplos e de Sa\u00fade (IIMS) 2023\u20132024 Relat\u00f3rio de Indicadores B\u00e1sicos. Luanda: INE; 2024. https:\/\/www.ine.gov.ao\/Arquivos\/arquivosCarregados\/\/Carregados\/Publicacao_638818795475855073.pdf. Accessed 27 Jan 2026."},{"key":"5856_CR56","first-page":"1","volume":"14","author":"V Foumane Ngane","year":"2015","unstructured":"Foumane Ngane V, Allico Djaman J, Culeux C, Piette N, Carnevale P, Besnard P, et al. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province. Angola Malar J. 2015;14:1\u20139.","journal-title":"Angola Malar J"},{"key":"5856_CR57","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1179\/2047773214Y.0000000158","volume":"108","author":"J Li","year":"2014","unstructured":"Li J, Chen J, Xie D, Monte-Nguba SM, Eyi JUM, Matesa RA, et al. High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island. Equatorial Guinea Pathog Glob Health. 2014;108:339\u201344.","journal-title":"Equatorial Guinea Pathog Glob Health"},{"key":"5856_CR58","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1128\/AAC.47.4.1347-1354.2003","volume":"47","author":"RJ Pearce","year":"2003","unstructured":"Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of Northern Tanzania. Antimicrob Agents Chemother. 2003;47:1347\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"5856_CR59","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4269\/ajtmh.23-0382","volume":"109","author":"I Molina-de la Fuente","year":"2023","unstructured":"Molina-de la Fuente I, Sagrado Benito MJ, Ousley J, Gisbert FB, Garc\u00eda L, Gonzalez V, et al. Screening for K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Yambio County (Western Equatoria State, South Sudan). Am J Trop Med Hyg. 2023;109:1072\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5856_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-025-00732-6","volume":"53","author":"A Mart\u00edn Ram\u00edrez","year":"2025","unstructured":"Mart\u00edn Ram\u00edrez A, Akindele AA, Gonz\u00e1lez Mora V, Garc\u00eda L, Lara N, de la Torre-Capit\u00e1n ME, et al. Mutational profile of pfdhfr, pfdhps, pfmdr1, pfcrt and pfk13 genes of Plasmodium falciparum associated with resistance to different antimalarial drugs in Osun State, Southwestern Nigeria. Trop Med Health. 2025;53:1\u201313.","journal-title":"Trop Med Health"},{"key":"5856_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11050554","volume":"11","author":"ABB Rodrigues","year":"2022","unstructured":"Rodrigues ABB, de Abreu-Fernandes R, Neto Z, Jandondo D, Almeida-De-Oliveira NK, de Lavigne Mello AR, et al. Pfkelch13 Plasmodium falciparum mutations in Huambo, Angola. Pathogens. 2022;11:554.","journal-title":"Pathogens"},{"key":"5856_CR62","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12936-020-3140-0","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang X, Ruan W, Zhou S, Huang F, Lu Q, Feng X, et al. Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018. Malar J. 2020;19:314.","journal-title":"Malar J"},{"key":"5856_CR63","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.4269\/ajtmh.17-0864","volume":"98","author":"T Zhang","year":"2018","unstructured":"Zhang T, Xu X, Jiang J, Yu C, Tian C, Li W. Surveillance of antimalarial resistance molecular markers in imported Plasmodium falciparum malaria cases in Anhui, China, 2012\u20132016. Am J Trop Med Hyg. 2018;98:1132\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5856_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1122-z","volume":"15","author":"C Fan\u00e7ony","year":"2016","unstructured":"Fan\u00e7ony C, Brito M, Gil JP. Plasmodium falciparum drug resistance in Angola. Malar J. 2016;15:1\u20139.","journal-title":"Malar J"},{"key":"5856_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116856","volume":"10","author":"S Chatio","year":"2015","unstructured":"Chatio S, Aborigo R, Adongo PB, Anyorigiya T, Akweongo P, Oduro A. Adherence and uptake of artemisinin-based combination treatments for uncomplicated malaria: a qualitative study in northern Ghana. PLoS ONE. 2015;10:e0116856.","journal-title":"PLoS ONE"},{"key":"5856_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-236","volume":"7","author":"P Figueiredo","year":"2008","unstructured":"Figueiredo P, Benchimol C, Lopes D, Bernardino L, Do Ros\u00e1rio VE, Varandas L, et al. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance in Luanda, Angola. Malar J. 2008;7:236.","journal-title":"Malar J"},{"key":"5856_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-248","volume":"10","author":"BE Gama","year":"2011","unstructured":"Gama BE, Pereira-Carvalho GAL, Lutucuta Kosi FJI, De Oliveira ANK, Fortes F, Rosenthal PJ, et al. Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola. Malar J. 2011;10:248.","journal-title":"Malar J"},{"key":"5856_CR68","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1186\/s12936-016-1358-7","volume":"15","author":"EPS Kaingona-Daniel","year":"2016","unstructured":"Kaingona-Daniel EPS, Gomes LR, Gama BE, Almeida-De-Oliveira NK, Fortes F, M\u00e9nard D, et al. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola. Malar J. 2016;15:1358.","journal-title":"Malar J"},{"key":"5856_CR69","volume":"12","author":"MP Dakorah","year":"2025","unstructured":"Dakorah MP, Aninagyei E, Attoh J, Adzakpah G, Tukwarlba I, Acheampong DO. Profiling antimalarial drug-resistant haplotypes in Pfcrt, Pfmdr1, Pfdhps and Pfdhfr genes in Plasmodium falciparum causing malaria in the Central Region of Ghana: a multicentre cross-sectional study. Ther Adv Infect Dis. 2025;12:20499361251319665.","journal-title":"Ther Adv Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05856-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05856-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05856-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:02:26Z","timestamp":1776906146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05856-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5856"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05856-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Vall d'Hebron University Hospital Drug Research Ethics Committee [PR(AG)79\/2024] and by the Ethics Committee of the Angolan Ministry of Health (39 C.E\/MINSA.INIS\/2022). Each participant signed an informed consent form (in the case of minors, parental\/guardian consent was obtained) after being informed of the objectives of the study. All procedures were performed according to the ethical guidelines of the 2013 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}